Literature DB >> 23190914

UK must improve its recruitment rate in clinical trials, report says.

Nigel Hawkes.   

Abstract

Mesh：

Year:  2012        PMID： 23190914     DOI： 10.1136/bmj.e8104

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Tolerating bad health research: the continuing scandal.

Authors:  Stefania Pirosca; Frances Shiely; Mike Clarke; Shaun Treweek
Journal:  Trials       Date:  2022-06-02       Impact factor: 2.728

2.  Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform.

Authors:  Shaun Treweek; Doug G Altman; Peter Bower; Marion Campbell; Iain Chalmers; Seonaidh Cotton; Peter Craig; David Crosby; Peter Davidson; Declan Devane; Lelia Duley; Janet Dunn; Diana Elbourne; Barbara Farrell; Carrol Gamble; Katie Gillies; Kerry Hood; Trudie Lang; Roberta Littleford; Kirsty Loudon; Alison McDonald; Gladys McPherson; Annmarie Nelson; John Norrie; Craig Ramsay; Peter Sandercock; Daniel R Shanahan; William Summerskill; Matt Sydes; Paula Williamson; Mike Clarke
Journal:  Trials       Date:  2015-06-05       Impact factor: 2.279

3.  ClinicalTrials.gov as a data source for semi-automated point-of-care trial eligibility screening.

Authors:  Pascal B Pfiffner; JiWon Oh; Timothy A Miller; Kenneth D Mandl
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

4.  Can a 'consent to contact' community help research teams overcome barriers to recruitment? The development and impact of the 'Research for the Future' community.

Authors:  Katherine Grady; Martin Gibson; Peter Bower
Journal:  BMC Med Res Methodol       Date:  2019-10-22       Impact factor: 4.615

5.  Cluster randomised trials of prescribing policy: an ethical approach to generating drug safety evidence? A discussion of the ethical application of a new research method.

Authors:  Amy Rogers; Gillian Craig; Angela Flynn; Isla Mackenzie; Thomas MacDonald; Alexander Doney
Journal:  Trials       Date:  2020-06-05       Impact factor: 2.279
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.